8.30am - 9.00am      Registration and morning coffee

9.00am - 9.15am

Welcome and Official Opening 
Rob Scott, Director, China BlueSky Partners

9.15am - 9.45am

KEYNOTE: The Growth Opportunity of Life Sciences in Australia
 Glenn Cross, Chief Executive Officer, AusBiotech

9.45am - 10.15am

PANEL: Big Pharma and China Pharma - What is the difference?

Moderator: Rob Scott, Director, China BlueSky Partners

Binhui Ni, Associate Vice President/Head, External Science and Partnering APAC, Sanofi
Paul Qi, Business Development Director, Buchang Pharma
Dr Xiaoming Zou, Chief Executive Officer, EOC Pharma

10.15am - 10.45am

Company Spotlight Presentations

David Ranson
ChairmanFivephusion Pty Ltd
Dr Michelle Miller,
CEO & Managing Director, Biotron Ltd
Dr Tony Keating,
CEO & Managing Director, ResApp Health

10.45am - 11.00am Morning Tea and networking opportunity

11.00am - 11.30am

PANEL: How to develop a successful medtech company in China

Moderator: Glenn Cross, Chief Executive Officer, AusBiotech Ltd

A/Prof David Anderson, President, Nanjing BioPoint Diagnostic Technology
Brendan Mason, Director, Sino-Oz
Barry Thomas, Chief Executive Officer, Cook Medical

11.30am - 12.00pm

Company Spotlight Presentations

Dr James Garner,
Chief Executive Officer, Novogen
A/Prof David Anderson, President, Nanjing BioPoint Diagnostic Technology
Geoff Drenkhahn, Director, HepSeeVax (Burnet Institute)
Michael Kleinig
, CEO & Managing Director, GO Resources

12.00pm - 1.10pm

Lunch and networking opportunity

1.10pm - 1.30pm

KEYNOTE: China Legal and IP considerations
Speaker: Annie Zhu, Partner, Shanghai Zhongxia Xubo Law Firm

1.30pm - 2.20pm

Company Spotlight Presentations

Philip Crealy,
Director - Translational Research, Petri Exchange
Tom Howitt,
Chief Financial Officer, Global Kinetics
Peter Molloy,
Managing Director & CEO, Race Oncology
Dr Richard Lipscombe,
Managing Director, Proteomics International
Dr Geoff Dow,
Chief Executive Officer, 60 Degrees Pharmaceuticals

2.20pm - 2.45pm

PANEL: What do Chinese VC's really want?

Moderator: Barry Palte, Deputy Chairman, BlueMount Capital

Donald Gao, Partner, Marathon Venture Capital
Bo Liu, Principal, Venture Investments JJDC
Forest Xu, Founder, Vi Ventures

2.45pm - 3.00pm

KEYNOTE: Helping Australian Healthcare companies navigate the Chinese Market
Speaker: Tom Ellis, Investment Director, MAI Capital

3:00pm - 3:15pm Afternoon tea and networking opportunity

3:15pm - 3:30pm Launch of In-Gage China Platform
Rob Scott,
Director, China BlueSky Partners

3:30pm - 4:00pm

PANEL: Navigating regulatory systems in Australia and China
Moderator: Brendan Mason, Director, Sino-Oz

Alan Garcia, Leader of R&D Tax Centre of Excellence, KPMG Advisory (China)
Jianjun Zhang, Business Development Director, Pharrell (Shanghai) Medical Development Co.
Jim Wu, Chief Executive Officer, Ark Biosciences


4:00pm - 4:15pm Wrap up and close of conference
Glenn Cross,
Chief Executive Officer, AusBiotech